Application

19505749 · PSMA-TARGETED RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER

Filed 2026-01-27 · Pending The official file ↗ · Art unit · Fusion Pharmaceuticals Inc. · ASTRAZENECA MEDIMMUNE

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.